Lv3
315 积分 2021-05-17 加入
Targeting aldosterone to improve cardiorenal outcomes: from nonsteroidal mineralocorticoid receptor antagonists to aldosterone synthase inhibitors
1年前
已完结
Emerging Therapies for Treatment-Resistant Hypertension: A Review of Lorundrostat and Related Selective Aldosterone Synthase Inhibitors
1年前
已完结
Lorundrostat in Participants With Uncontrolled Hypertension and Treatment-Resistant Hypertension
1年前
已完结
Lorundrostat Efficacy and Safety in Patients with Uncontrolled Hypertension
1年前
已完结
皖公网安备34019202002308
